Subacute cutaneous lupus erythematosus versus systemic lupus erythematosus: diagnostic criteria and therapeutic implications
- PMID: 9520021
- DOI: 10.1016/s0190-9622(98)70497-9
Subacute cutaneous lupus erythematosus versus systemic lupus erythematosus: diagnostic criteria and therapeutic implications
Abstract
Background: The nosologic position of subacute cutaneous lupus erythematosus (SCLE) is controversial. More than four American Rheumatism Association (ARA) criteria for systemic lupus erythematosus (SLE) are found in a proportion of patients diagnosed as having SCLE; thus such cases could be classified as SLE.
Objective: Our purpose was to determine whether ARA criteria for SLE are helpful in differentiating SCLE from SLE and whether cutaneous and visceral changes, immunologic findings, and photosensitivity provide a basis for diagnosis of SCLE.
Methods: A cohort of 143 patients (79 with SCLE, 58 with SLE, and six with overlapping features of SCLE and SLE) was studied clinically, histologically, and immunologically as well as by phototesting. The patients were observed for up to 10 years, and the course of the disease and response to therapy were evaluated in each group.
Results: SCLE differed from SLE by cutaneous changes, significantly less frequent kidney involvement, serositis and arthritis, and the rare presence of double-stranded DNA, U1RNP, and Sm antibodies characteristic of SLE. Ro(SS-A) and La(SS-B) antibodies were detected with similar frequency, and photosensitivity was not related to the presence of Ro antibody. In contrast, photoreproduction (appearance of LE lesion in irradiated area) was significantly more frequent in patients with SCLE. The course of SCLE in older patients was less severe than in younger patients, and aggressive therapy was usually not required.
Conclusion: Patients with SCLE (although the majority fulfill more than four ARA criteria for SLE) show significant differences from those with SLE in terms of cutaneous and visceral involvement, immunologic findings, photosensitivity, course of the disease, and the requirement for therapy. Therefore SCLE should be recognized as a separate subset. However, cases of overlapping SLE and SCLE suggest a close relation.
Comment in
-
Subacute cutaneous lupus erythematosus versus systemic lupus erythematosus.J Am Acad Dermatol. 1999 Jan;40(1):129-31. doi: 10.1016/s0190-9622(99)70548-7. J Am Acad Dermatol. 1999. PMID: 9922032 No abstract available.
Similar articles
-
Using the American College of Rheumatology (ACR) and Systemic Lupus International Collaborating Clinics (SLICC) criteria to determine the diagnosis of systemic lupus erythematosus (SLE) in patients with subacute cutaneous lupus erythematosus (SCLE).J Am Acad Dermatol. 2016 May;74(5):862-9. doi: 10.1016/j.jaad.2015.12.029. Epub 2016 Feb 18. J Am Acad Dermatol. 2016. PMID: 26897388 Free PMC article.
-
Systemic lupus erythematosus: clinical expression and anti-Ro/SS--a response in patients with and without lesions of subacute cutaneous lupus erythematosus.Lupus. 1997;6(1):32-9. doi: 10.1177/096120339700600105. Lupus. 1997. PMID: 9116716
-
Markers in cutaneous lupus erythematosus indicating systemic involvement. A multicenter study on 296 patients.Acta Derm Venereol. 1997 Jul;77(4):305-8. doi: 10.2340/0001555577305308. Acta Derm Venereol. 1997. PMID: 9228225
-
Drug-induced lupus erythematosus.Arch Dermatol Res. 2009 Jan;301(1):99-105. doi: 10.1007/s00403-008-0895-5. Epub 2008 Sep 17. Arch Dermatol Res. 2009. PMID: 18797892 Review.
-
Cutaneous lupus erythematosus: issues in diagnosis and treatment.Am J Clin Dermatol. 2009;10(6):365-81. doi: 10.2165/11310780-000000000-00000. Am J Clin Dermatol. 2009. PMID: 19824738 Review.
Cited by
-
Paraneoplastic cutaneous lupus secondary to esophageal squamous cell carcinoma.J Gastrointest Oncol. 2015 Jun;6(3):E61-5. doi: 10.3978/j.issn.2078-6891.2015.018. J Gastrointest Oncol. 2015. PMID: 26029469 Free PMC article.
-
Subacute Cutaneous Lupus Erythematosus Secondary to Intravenous Immunoglobulin Infusions.Cureus. 2024 Jun 26;16(6):e63217. doi: 10.7759/cureus.63217. eCollection 2024 Jun. Cureus. 2024. PMID: 39070403 Free PMC article.
-
Cutaneous Lupus Erythematosus: Review and Considerations for Older Populations.Drugs Aging. 2024 Jan;41(1):31-43. doi: 10.1007/s40266-023-01079-5. Epub 2023 Nov 22. Drugs Aging. 2024. PMID: 37991658 Review.
-
James Neil Gilliam, MD-the career arc of a patient-oriented translational clinical investigation changemaker in rheumatologic skin disease.Ann Transl Med. 2018 Jun;6(11):217. doi: 10.21037/atm.2018.05.20. Ann Transl Med. 2018. PMID: 30023380 Free PMC article.
-
Complement-4 deficiency in a child with systemic lupus erythematosus presenting with standard treatment-resistant severe skin lesion.ISRN Rheumatol. 2011;2011:917673. doi: 10.5402/2011/917673. Epub 2011 Feb 10. ISRN Rheumatol. 2011. PMID: 22482068 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials